61132 Federal Register / Vol. 62, No. 220 / Friday, November 14, 1997 / Notices

This notice is issued under the

Federal Food, Drug, and Cosmetic Act

(secs. 515(d), 520(h) (21 U.S.C. 360e(d),

360j(h))) and under authority delegated

to the Commissioner of Food and Drugs

(21 CFR 5.10) and redelegated to the

Director, Center for Devices and

Radiological Health (21 CFR 5.53).

Dated: October 16, 1997.

Joseph A. Levitt,

Deputy Director for Regulations Policy, Center

for Devices and Radiological Health.

[FR Doc. 97–30030 Filed 11–13–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Psychopharmacologic Drugs Advisory

Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). The meeting will be open to the

public.

Name of Committee:

Psychopharmacologic Drugs Advisory

Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on FDA

regulatory issues.

Date and Time: The meeting will be

held on December 4, 1997, 8:30 a.m to

5 p.m.

Location: Holiday Inn, Versailles

Ballrooms I and II, 8120 Wisconsin

Ave., Bethesda, MD.

Contact Person: Rhonda W. Stover, or

Robinette Taylor, Center for Drug

Evaluation and Research (HFD–21),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–443–5455, or FDA Advisory

Committee Information Line, 1–800–

741–8138 (301–443–0572 in the

Washington, DC area), code 12544.

Please call the Information Line for upto-date information on this meeting.

Agenda: On December 4, 1997, the

committee will hear presentations from

the Institute of Medicine on the

marketed product Halcion (triazolam,

Pharmacia and Upjohn Co.).

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by December 1, 1997. Oral

presentations from the public will be

scheduled between approximately 8:30

a.m. and 9:30 a.m. Time allotted for

each presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person before December 1, 1997, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: November 10, 1997.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 97–30034 Filed 11–13–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

Periodically, the Health Resources

and Services Administration (HRSA)

publishes abstracts of information

collection requests under review by the

Office of Management and Budget, in

compliance with the Paperwork

Reduction Act of 1995 (44 U.S.C.

Chapter 35). To request a copy of the

clearance requests submitted to OMB for

review, call the HRSA Reports

Clearance Office on (301) 443–1129.

The following request has been

submitted to the Office of Management

and Budget for review under the

Paperwork Reduction Act of 1995:

Proposed Project: The Health

Education Assistance Loan (HEAL)

Program: Application Form—0915–

0038—Extension, No Change. The

Health Education Assistance Loan

(HEAL) program provides federallyinsured loans to students in schools of

allopathic medicine, osteopathic

medicine, dentistry, veterinary

medicine, optometry, podiatric

medicine, pharmacy, public health,

allied health, or chiropractic, and

graduate students in health

administration or clinical psychology.

Eligible lenders, such as banks, savings

and loan associations, credit unions,

pension funds, State agencies, HEAL

schools, and insurance companies,

make HEAL loans which are insured by

the Federal Government against loss due

to borrowers’ death, disability,

bankruptcy, and default. The basic

purpose of the program is to assure the

availability of funds for loans to eligible

students who need to borrow money to

pay for their educational costs.

The HEAL program is being phased

out and no new loans will be made after

September 30, 1998, unless

reauthorization is enacted. We are,

however, requesting a 3-year extension

of the OMB approval of the HEAL

Application Form HRSA–700 because

lenders will continue to use this form

for consolidation loans through fiscal

year (FY) 2000. Students use the

application to apply for HEAL loans

(through FY 1998) and consolidation of

loans, schools use the application to

determine a student’s eligibility and

maximum approval amount of each loan

(through FY 1998 only), and lenders use

the application to determine student

eligibility and the amount of the

installment or disbursement to be given

to the borrower, and to process

consolidation loans.

The estimate of burden for the

application form for FY 1998 is as

follows:

Type of respondent Number of

respondents

Responses

per

respondent

Total

number of

responses

Burden per

response

(minutes)

Total

burden

hours

Applicants ................................................................................................. 8,230 1 8,230 25 3,429

Schools ..................................................................................................... 190 41 7,730 32 4,123

Lenders ..................................................................................................... 11 748 8,230 35 4,801

Total ............................................................................................... 8,431 .................... 24,190 .................... 12,353

The estimate of burden for the application form for FY 1999 and 2000 (for consolidation loans only) is as follows:
Federal Register / Vol. 62, No. 220 / Friday, November 14, 1997 / Notices 61133

Type of respondent Number of

respondents

Responses

per

respondent

Total

number of

responses

Burden per

response

(minutes)

Total

burden

hours

Applicants ................................................................................................. 500 1 500 25 208

Lenders ..................................................................................................... 11 45 500 35 292

Total ............................................................................................... 511 .................... 1,000 .................... 500

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Laura Oliven, Human Resources and

Housing Branch, Office of Management

and Budget, New Executive Office

Building, Room 10235, Washington, DC

20503.

Dated: November 7, 1997.

Jane M. Harrison,

Acting Director, Division of Policy Review

and Coordination.

[FR Doc. 97–30027 Filed 11–13–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

The Health Resources and Services

Administration

Notice of a Cooperative Agreement

with the American Public Health

Association

The Health Resources and Services

Administration’s (HRSA) HIV/AIDS

Bureau announces that it will award a

sole source cooperative agreement to the

American Public Health Association

(APHA).

The purpose of this cooperative

agreement is to assist, collaboratively

with APHA, in the development and

dissemination of resource materials

relating to the care and treatment of

individuals with HIV/AIDS and the

prevention of the disease among

individuals who are at risk. In addition,

this agreement will assist with the

training of health professionals in the

care, treatment, and prevention of HIV/

AIDS. Specifically, these activities will

include, but not be limited to,

identifying areas where best practice

standards need to be investigated and

developed; identifying and developing

science expertise in areas agreed to by

HRSA as critical to the appropriate

delivery of HIV/AIDS care; using that

expertise to develop best practices; and

disseminating to the public health

community information on best

practices.

HRSA will provide consultation,

including administrative and technical

assistance as needed, for the execution

and evaluation of all aspects of this

cooperative agreement. HRSA may also

participate and/or collaborate with the

APHA in any workshops or symposia to

exchange current information, opinions,

and research findings during this

agreement.

The goal of HRSA in entering into this

cooperative agreement is to strengthen

effective HIV/AIDS treatment programs

at all levels throughout the United

States and its territories; to prevent HIV

transmission and effect, maintain,

measure, and evaluate behavioral

change among individuals whose

behavior places them at risk of HIV

infection; to reduce risks of further

transmission and to maintain the health

of asymptomatic clients; and to increase

collaboration, support and technical

competence among agencies,

organizations, groups, and

constituencies.

Authorizing Legislation

This cooperative agreement is

authorized under Section 2692 of the

Public Health Service Act.

Background

Assistance will be provided to the

American Public Health Association. No

other applications are solicited. The

HIV/AIDS Bureau is committed to

providing program expertise throughout

the nation to ensure that the providers

of HIV/AIDS services to underserved

and vulnerable populations deliver

appropriate and quality care. The

Bureau believes that APHA is uniquely

qualified to work with HRSA to meet

this goal for the following reasons:

1. APHA has more than 50,000

members and affiliates from 50

occupations of public health, including

medicine, social work, nursing, health

education, epidemiology, and program

evaluation. It represents all disciplines

and specialities of public health. It

stimulates and coordinates the

development of the scientific basis for

the Association’s professional and

public health policy programs. The

development of a public health HIV/

AIDS science and service delivery

assistance program with APHA

automatically covers all relevant

disciplines and specialities needed for

this effort. Because of the rapidly

changing field of HIV/AIDS service

delivery, it is impossible to predict

which expertise will be needed of the 50

public health occupations.

2. The mission of this organization is

to ‘‘prevent disease and promote health’’

throughout the United States making

APHA a national leader. APHA has a

history of providing science expertise to

develop best practices for the delivery of

public health programs, including HIV/

AIDS services. Currently, it provides

professional education and services for

its members in a variety of areas. The

APHA has valuable experience with

issues important to the delivery of HIV/

AIDS care—health care in jails and

prisons, outreach to underserved

groups, women’s health, and primary

health care delivery in community

settings. This experience enables the

APHA to contribute significantly to this

effort. APHA can identify areas needing

best practices, identify experts in these

areas, and assign individual experts and

groups to develop best practices.

3. APHA has established relationships

with the major associations that

represent single public health

disciplines, such as the American

Medical Association, and associations

that represent health profession schools,

such as the Association of Schools of

Public Health. It can use these ties to

further identify needed experts in the

HIV/AIDS service field.

Approximately $100,000 is available

in fiscal year 1997 for the first year of

a 3-year project period for this

cooperative agreement. Continuation

awards within the project period will be

made on the basis of satisfactory

progress and the availability of funds.

Where To Obtain Additional

Information

If you are interested in obtaining

additional information regarding this

project, contact Mr. William Aspden,

HIV/AIDS Bureau, HRSA, 5600 Fishers

Lane, Room 7–05, Rockville, Maryland

20857 or telephone (301) 443–1993.

Dated: November 7, 1997.

Claude Earl Fox,

Acting Administrator.

[FR Doc. 97–30026 Filed 11–13–97; 8:45 am]

BILLING CODE 4160–15–P